Clinical Trial Update: Buprenorphine Induction for Fentanyl Dependent Opioid Users [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial evaluating buprenorphine induction for fentanyl-dependent opioid users has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Opioid Dependence Fentanyl | EARLY_Phase 1 | Status: WITHDRAWN